A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)

By sjmartinez • February 15, 2023

Khanna D, Denton CP, Furst DE, Mayes MD, Matucci-Cerinic M, Smith V, de Vries D, Ford P, Bauer Y, Randall MJ, Ebrahimpoor M, Kupcsik L, Stiers PJ, Deberdt L, Prasad N, Lim S, Pujuguet P, Ahmed S. A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA). Arthritis Rheumatol. 2023 Feb 14. doi: 10.1002/art.42477. Epub ahead of print. PMID: 36787101.

Tags: Publications, Rheumatology

Closed-Loop Multimodal Neuromodulation of Vagus Nerve for Control of Heart Rate

Bender SA, Green DB, Kilgore KL, Bhadra N, Ardell JL, Vrabec TL. Closed-Loop Multimodal Neuromodulation of Vagus Nerve for Control of Heart Rate. Proc Am[...]

Ventricular Tachycardia Storm in a Young Adult Post-ALCAPA Repair

Jeong SY, Hayase J, Moore J, Bender A, Do D, Sanchez DR, Doris JM. Ventricular Tachycardia Storm in a Young Adult Post-ALCAPA Repair. JACC Case Rep.[...]

Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for[...]